CaMKII confirms its promise in ischaemic heart disease

Ralph J. van Oort, Joan Heller Brown, B. Daan Westenbrink^*

^*Bijbehorende auteur voor dit werk

Onderzoeksoutput: Editorial › Academic › peer review

3 Citaten (Scopus)

Originele taal-2	English
Pagina's (van-tot)	1268-1269
Aantal pagina's	2
Tijdschrift	European Journal of Heart Failure
Volume	16
Nummer van het tijdschrift	12
DOI's	https://doi.org/10.1002/ejhf.204
Status	Published - dec-2014

Toegang tot document

@article{a2aa1fb7baee4ece8be11e8278f06f2b,

title = "CaMKII confirms its promise in ischaemic heart disease",

keywords = "ISCHEMIA/REPERFUSION INJURY, PHOSPHORYLATION, FAILURE, INHIBITION",

author = "{van Oort}, {Ralph J.} and Brown, {Joan Heller} and Westenbrink, {B. Daan}",

year = "2014",

month = dec,

doi = "10.1002/ejhf.204",

language = "English",

volume = "16",

pages = "1268--1269",

journal = "European Journal of Heart Failure",

issn = "1388-9842",

publisher = "Wiley",

number = "12",

}

TY - JOUR

T1 - CaMKII confirms its promise in ischaemic heart disease

AU - van Oort, Ralph J.

AU - Brown, Joan Heller

AU - Westenbrink, B. Daan

PY - 2014/12

Y1 - 2014/12

KW - ISCHEMIA/REPERFUSION INJURY

KW - PHOSPHORYLATION

KW - FAILURE

KW - INHIBITION

U2 - 10.1002/ejhf.204

DO - 10.1002/ejhf.204

M3 - Editorial

VL - 16

SP - 1268

EP - 1269

JO - European Journal of Heart Failure

JF - European Journal of Heart Failure

SN - 1388-9842

IS - 12

ER -